Anaplastic Large Cell Lymphoma Terminated Phase 1 / 2 Trials for SGN-30 (DB05471)

Also known as: Lymphomas, Anaplastic Large-Cell / Anaplastic large-cell lymphoma / Large cell (Ki-1+) lymphoma / Lymphoma, Large-Cell, Anaplastic / Anaplastic large cell lymphoma, CD30-positive

DBCOND0028602 (Anaplastic Large Cell Lymphoma)Terminated1 / 2 IdentifierTitlePurposeDrugs
NCT00354107Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell LymphomaTreatment